| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.28 | 0.05 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.25 | 0.05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.06 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.06 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.33 | 0.06 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |